Tag: target lesion primary patency
Lutonix AV global registry shows higher target lesion primary patency when...
In a new post-hoc analysis of the Lutonix (BD) arteriovenous (AV) global registry using investigational device exemption (IDE) criteria, Dimitrios Karnabatidis (Patras University Hospital,...
